ClinicalTrials.gg
CompletedNCT04072536SWADAPT1Updated Sep 21, 2026

Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving 1

An interventional study of Electric wheelchair with activated assistance module and Electric wheelchair with assistance module not activated in Neurological Disorders, sponsored by Pôle Saint Hélier. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Pôle Saint Hélier · Not applicable, Interventional, and Other

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
25
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.

Read the detailed description

The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.

Each patient included will test a wheelchair equipped with a collision avoidance assistance module in 2 conditions, assistance activated or not. This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance, in a random order established upstream.

02

Conditions studied

  • Neurological Disorders
03

In context

Nervous System Diseases

759 studies on the registry are indexed under Nervous System Diseases; 217 are open to participants now.

This study's enrollment of 25 is below the median of 55 across 496 interventional studies indexed under Nervous System Diseases.

Browse Nervous System Diseases studies →

Lead sponsor

Pôle Saint Hélier is the lead sponsor of 23 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged over 18,
  • Having freely consented to participate in the study,
  • suffering from neurological disorders such as cerebro-lesion or neuro-degeneration,
  • Having benefited from a prescription of electric wheelchair and circulating in an electric wheelchair for more than 3 months,
  • of which the electric wheelchair is the main mode of transport,
  • The physical measurements (weight, height) are compatible with the use of the electric wheelchair chosen for the development of the robotics assistance module.

Exclusion criteria

Exclusion Criteria:

  • Understanding difficulties preventing the realization of the protocol,
  • Motor disorders of the upper limb requiring additional driving technical assistance,
  • Patient having expressed difficulties impacting his safety of sedan and / or exterior.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
25 participants (actual)

Study arms

  • Experimental
    Electric wheelchair with activated assistance module

    This condition will be achieved in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance, in a random order established upstream.

    Device: Electric wheelchair with activated assistance module

  • Other
    Electric wheelchair with assistance module not activated

    This condition will be achieved in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 without activated assistance, in a random order established upstream.

    Device: Electric wheelchair with assistance module not activated

Interventions

  • DeviceElectric wheelchair with activated assistance module

    This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance

  • DeviceElectric wheelchair with assistance module not activated

    This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with no activated assistance

06

What researchers measure

Primary outcomes

  1. Number of collision

    The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module.

    Time frame: Day 1

  2. Number of collision

    The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module.

    Time frame: Day 8

  3. Number of collision

    The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module.

    Time frame: Day 15

Secondary outcomes

  1. Driving Speed

    Speed measured by the completion time of the course with and without activation of the assistance system on the different circuits

    Time frame: Day 1, Day 8 and Day 15

  2. Wheelchair Skill Test

    Driving performance measured by the Wheelchair Skill Test items corresponding to the different courses, with and without activation of the assistance system

    Time frame: Day 1, Day 8 and Day 15

  3. NASA-Task Load Index

    The cognitive load of tests under both conditions will be measured by the NASA-Task Load Index. It is in the form of six scales where the participant must assign a score between zero and one hundred to each of them, score indicating a growing level of intensity. Three dimensions relate to the demands imposed on the subject (mental, physical and temporal demands) and three to the interaction of a subject with the task (effort, frustration and performance)

    Time frame: Day 1, Day 8 and Day 15

  4. Ease of Use Questionnaire

    The satisfaction of the use of the electric wheelchair under the conditions will be evaluated by the self-questionnaire Ease of Use Questionnaire. It measures the subjective usability of a product or service. It is a 30-item survey that examines four dimensions of usability: usefulness, ease of use, ease of learning, and satisfaction. The questionnaires were constructed as seven-point Likert rating scales. Users were asked to rate agreement with the statements, ranging from strongly disagree (1) to strongly agree (7).

    Time frame: Day 1, Day 8 and Day 15

  5. UTAUT (Unified theory of acceptance of technology) questionnaire

    Questionnaire of acceptability / acceptance of the tool and its use by patients based on the Unified Theory of Acceptance and Use Technology (UTAUT).

    Time frame: Day 1, Day 8 and Day 15

07

Study locations

1 site
  • Pôle Saint-Hélier
    Rennes, Brittany Region 35000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2019 to primary completion in Jun 2019, 0 months.

Of 168 non-industry interventional studies with no phase under Nervous System Diseases, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 57. This study's 0 months is below that.

Counting every sponsor, half of 194 studies reached it within 30 months; a quarter within 11 and three quarters within 54.

Nervous System Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 21, 2019
First posted
Aug 28, 2019
StartActual
Jun 3, 2019
Primary completionActual
Jun 18, 2019
CompletionActual
Jun 18, 2019
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04072536
Lead sponsor
Pôle Saint Hélier
Responsible party
Sponsor
First posted
Aug 28, 2019
Start date
Jun 3, 2019
Primary completion
Jun 18, 2019
Completion
Jun 18, 2019
Last update
Sep 21, 2026

Study contacts

Philippe Gallien, Doctor
principal investigator · Pôle Saint Hélier

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion